organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 67| Part 9| September 2011| Pages o2272-o2273

3-(4-Chloro­benzene­sulfonamido)-5-methyl­cyclo­hex-2-en-1-one

aCollege of Pharmacy, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA, bDepartment of Pharmaceutical Sciences, Howard University, 2300 4th Street NW, Washington, DC 20059, USA, and cDepartment of Chemistry, Howard University, 525 College Street NW, Washington, DC 20059, USA
*Correspondence e-mail: rbutcher99@yahoo.com

(Received 25 July 2011; accepted 29 July 2011; online 6 August 2011)

For the title compound, C13H14ClNO3S, geometrical parameters, determined using X-ray diffraction techniques, are compared with those calculated by density functional theory (DFT), using hybrid exchange-correlation functional, B3LYP methods. The dihedral angle between the benzene ring and the conjugated part of the cyclo­hexene ring is 87.47 (5)°. The cyclo­hexene ring and its substituents are disordered over two conformations, with occupancies of 0.786 (3) and 0.214 (3). In the crystal, mol­ecules are linked into chains in the c-axis direction by inter­molecular N—H⋯O(C=O) hydrogen bonds. C—H⋯O inter­actions are also observed.

Related literature

For the crystal growth of the title compound, see: Assey (2010[Assey, G. (2010). PhD dissertation, Howard University, Washington, DC, USA.]). For related enaminone structures and properties, see: Edafiogho et al. (2006[Edafiogho, I. O., Ananthalakshmi, K. V. & Kombian, S. B. (2006). Bioorg. Med. Chem. 14, 5266-5272.], 2007[Edafiogho, I. O., Kombian, S. B., Ananthalakshmi, K. V., Salama, N. N., Eddington, N. D., Wilson, T. L., Alexander, M. S., Jackson, P. L., Hanson, C. D. & Scott, K. R. (2007). J. Pharm. Sci. 96, 2509-2531.]); Eddington et al. (2000[Eddington, N. D., Cox, D. S., Roberts, R. R., Stables, J. P., Powell, C. B. & Scott, K. R. (2000). Curr. Med. Chem. 7, 417-36.]); Jackson (2009[Jackson, P. L. (2009). PhD dissertation, Howard University, Washington, DC, USA.]); Michael et al. (1996[Michael, J. P., de Koning, C. B. & Stanbury, T. V. (1996). Tetrahedron Lett. 37, 9403-9406.], 2001[Michael, J. P., de Koning, C. B., Hosken, G. D. & Stanbury, T. V. (2001). Tetrahedron, 57, 9635-9648.]). For their anti-convulsant activity, see: Stables & Kupferburg (1997[Stables, J. P. & Kupferburg, H. J. (1997). The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project. pp. 191-198. London: John Libbey and Co.]). For information related to GAUSSIAN software, see: Frisch et al. (2004[Frisch, M. J., et al. (2004). GAUSSIAN03. Gaussian Inc., Wallingford, CT, USA.])

[Scheme 1]

Experimental

Crystal data
  • C13H14ClNO3S

  • Mr = 299.76

  • Monoclinic, P 21 /c

  • a = 10.2031 (2) Å

  • b = 10.3267 (3) Å

  • c = 14.1217 (3) Å

  • β = 108.989 (3)°

  • V = 1406.95 (6) Å3

  • Z = 4

  • Cu Kα radiation

  • μ = 3.83 mm−1

  • T = 295 K

  • 0.76 × 0.61 × 0.31 mm

Data collection
  • Oxford Diffraction Gemini R diffractometer

  • Absorption correction: analytical [CrysAlis RED (Oxford Diffraction, 2009[Oxford Diffraction (2009). CrysAlis PRO and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.]), based on expressions derived by Clark & Reid (1995[Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897.])] Tmin = 0.119, Tmax = 0.355

  • 5137 measured reflections

  • 2778 independent reflections

  • 2547 reflections with I > 2σ(I)

  • Rint = 0.047

Refinement
  • R[F2 > 2σ(F2)] = 0.083

  • wR(F2) = 0.250

  • S = 1.07

  • 2778 reflections

  • 205 parameters

  • 18 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • Δρmax = 1.26 e Å−3

  • Δρmin = −0.65 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
N—H1N⋯O3Bi 0.83 (2) 1.91 (2) 2.729 (10) 166 (2)
N—H1N⋯O3Ai 0.83 (2) 1.95 (2) 2.777 (3) 171 (2)
C5—H5A⋯O2ii 0.93 2.53 3.337 (3) 145
Symmetry codes: (i) [x, -y+{\script{3\over 2}}, z+{\script{1\over 2}}]; (ii) [-x+2, y-{\script{1\over 2}}, -z+{\script{3\over 2}}].

Data collection: CrysAlis CCD (Oxford Diffraction, 2009[Oxford Diffraction (2009). CrysAlis PRO and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.]); cell refinement: CrysAlis RED (Oxford Diffraction, 2009[Oxford Diffraction (2009). CrysAlis PRO and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.]); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.

Supporting information


Comment top

Enaminone analogues are reported to possess antiflammatory (Eddington et al., 2000) antimalarial (Edafiogho et al., 2006), antibacterial (Michael et al., 1996, 2001), and anticonvulsant properties (Edafiogho et al., 2007). Over recent years studies have shown that enaminones and their derivatives have played a major role in anti-epileptic activity and a number of structurally diverse anticonvulsant active enaminone analogues have been synthesized in our laboratory. We have provided several enaminones and their derivatives that are highly active in anticonvulsant studies. Our recent research has produced a novel series of benzene sulfonamide enaminones that are active in anticonvulsant studies. One of the compounds, [3-[(4'-chloro)benzenesulfonylamino]-5-methylcyclohex-2-enone, has been studied by pharmacology, X-ray and DFT studies (Jackson, 2009; Assey, 2010). Pharmacology was performed at the National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Health (NIH) (Stables & Kupferburg, 1997). Density-functional theory (DFT) and Hartree-Fock calculations and full-geometry optimizations were performed by means of the GAUSSIAN 03 W package (Frisch, et al., 2004). The selected bond lengths and angles obtained from HF and DFT/B3LYP are given in Table 2.

The structure of the title compound, 3-[(4'-chloro)benzenesulfonylamino]-5-methylcyclohex-2-enone, C13H14ClNO3S, the shape of the molecule is important in determining binding to the receptor sites thus it is of interest to note that the dihedral angle between the phenyl ring and the conjugated part of the cyclohexene ring is 87.47 (5)°. The cyclohexene and its substituents are disordered over two conformations with occupancies of 0.786 (3) and 0.214 (3), respectively. The molecules are linked in chains in the c direction by intermolecular N—H···O(C=O) hydrogen bonds.

Related literature top

For the crystal growth of the title compound, see: Assey (2010). For related enaminone structures and properties, see: Edafiogho et al. (2006, 2007); Eddington et al. (2000); Jackson (2009); Michael et al. (1996, 2001). For their anti-convulsant activity, see: Stables & Kupferburg (1997). For information related to GAUSSIAN software, see: Frisch et al. (2004)

Experimental top

3-amino-5-methylcyclohex-2-enone (2.00 g, 16 mmol) and NaH (1.07 g, 44.8 mmol) in dry THF refluxed for 1 h. After cooling, a solution of p-chlorobenzenesulfonyl chloride (3.42 g, 16.2 mmol) in 30 ml of dry THF was added dropwise. The reaction mixture was allowed to reflux for 1 h. Upon workup, the mixture is cooled to room temperature and quenched with 150 ml of deionized H2O and acidified with 12 ml of concentrated HCl. The aqueous solution was extracted with dichloromethane (2 x 100 ml) and the organic layer washed with 80 ml of water. The organic phase was dried over MgSO4, filtered, and evaporated in vacuo at a temperature not exceeding 35°C (32% yield) (1.54 g), as a white powder from methylene chloride, mp 191–193°C. νmax (cm-1) = νNH 3093 (w); νsp2 3031 (CH stretch; w); νC=O 1615 (m); νC=C 1609 and 1476 (aromatic); νS=O 1332(asymmetric; m) and 1141 (symmetric; m); νCN 1164 (s, sh); and νCl-aryl 1088 (m, sh). 1H NMR: δ (DMSO-d6) 0.915 (3H, d, CH3); 1.86–2.40 (5H, m, cyclohexene ring); 5.54 (1H, s, =CH); 7.76–7.86 (4H, dd, aromatic ring); 10.90 (1H, s, NH). Anal. Calculated for C13H14ClN2O5S: C, 52.09; H, 4.71; N, 4.67; S, 10.70. Found: C, 52.03; H, 4.59; N, 4.30; S, 10.67. Crystals of 3-[(4'-chloro)benzenesulfonylamino]-5-methylcyclohex-2-enone were obtained by slow evaporation from acetonitrile.

Refinement top

H atoms were placed in geometrically idealized positions and constrained to ride on their parent atoms with a C—H distance between 0.93 and 0.98 Å Uiso(H) = 1.2Ueq(C) and 0.96 Å for CH3 [Uiso(H) = 1.5Ueq(C)]. The H atom attached to N was refined isotropically. The the cyclohexene ring and its substituents were disordered over two conformations with occupancies of 0.786 (3) and 0.214 (3), respectively.

Computing details top

Data collection: CrysAlis CCD (Oxford Diffraction, 2009); cell refinement: CrysAlis RED (Oxford Diffraction, 2009); data reduction: CrysAlis RED (Oxford Diffraction, 2009); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).

Figures top
[Figure 1] Fig. 1. Diagram of 3-[(4'-chloro)benzenesulfonylamino]-5-methylcyclohex-2-enone showing the major component. Thermal ellipsoids drawn at the 30% probability level.
[Figure 2] Fig. 2. The molecular packing for 3-[(4'-chloro)benzenesulfonylamino]-5-methylcyclohex-2-enone viewed down the a axis. Intermolecular interactions are shown by dashed lines.
3-(4-Chlorobenzenesulfonamido)-5-methylcyclohex-2-en-1-one top
Crystal data top
C13H14ClNO3SF(000) = 624
Mr = 299.76Dx = 1.415 Mg m3
Monoclinic, P21/cCu Kα radiation, λ = 1.54184 Å
Hall symbol: -P 2ybcCell parameters from 4047 reflections
a = 10.2031 (2) Åθ = 4.3–77.2°
b = 10.3267 (3) ŵ = 3.83 mm1
c = 14.1217 (3) ÅT = 295 K
β = 108.989 (3)°Large plate, colorless
V = 1406.95 (6) Å30.76 × 0.61 × 0.31 mm
Z = 4
Data collection top
Oxford Diffraction Gemini R
diffractometer
2778 independent reflections
Radiation source: fine-focus sealed tube2547 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.047
Detector resolution: 10.5081 pixels mm-1θmax = 77.7°, θmin = 4.6°
ϕ and ω scansh = 1211
Absorption correction: analytical
[CrysAlis RED (Oxford Diffraction, 2009), based on expressions derived by Clark & Reid (1995)]
k = 1112
Tmin = 0.119, Tmax = 0.355l = 1716
5137 measured reflections
Refinement top
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.083H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.250 w = 1/[σ2(Fo2) + (0.183P)2 + 0.6772P]
where P = (Fo2 + 2Fc2)/3
S = 1.07(Δ/σ)max = 0.001
2778 reflectionsΔρmax = 1.26 e Å3
205 parametersΔρmin = 0.65 e Å3
18 restraintsExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.0074 (13)
Crystal data top
C13H14ClNO3SV = 1406.95 (6) Å3
Mr = 299.76Z = 4
Monoclinic, P21/cCu Kα radiation
a = 10.2031 (2) ŵ = 3.83 mm1
b = 10.3267 (3) ÅT = 295 K
c = 14.1217 (3) Å0.76 × 0.61 × 0.31 mm
β = 108.989 (3)°
Data collection top
Oxford Diffraction Gemini R
diffractometer
2778 independent reflections
Absorption correction: analytical
[CrysAlis RED (Oxford Diffraction, 2009), based on expressions derived by Clark & Reid (1995)]
2547 reflections with I > 2σ(I)
Tmin = 0.119, Tmax = 0.355Rint = 0.047
5137 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.08318 restraints
wR(F2) = 0.250H atoms treated by a mixture of independent and constrained refinement
S = 1.07Δρmax = 1.26 e Å3
2778 reflectionsΔρmin = 0.65 e Å3
205 parameters
Special details top

Experimental. CrysAlis RED (Oxford Diffraction , 2009) Analytical numeric absorption correction using a multifaceted crystal model based on expressions derived by R.C. Clark & J.S. Reid. (Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897)

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/UeqOcc. (<1)
Cl1.22572 (8)0.52485 (10)0.58620 (7)0.0804 (3)
S0.75611 (6)0.92036 (5)0.56637 (4)0.04691 (16)
O10.7602 (2)1.02174 (17)0.49885 (16)0.0609 (5)
O20.7649 (2)0.9502 (2)0.66719 (15)0.0706 (6)
N0.60950 (18)0.84131 (18)0.52132 (10)0.0412 (4)
H1N0.591 (2)0.802 (2)0.5668 (14)0.048 (7)*
C10.8877 (2)0.8073 (2)0.56969 (17)0.0441 (5)
C20.9599 (3)0.8170 (3)0.5024 (2)0.0538 (6)
H2A0.93850.88170.45400.065*
C31.0638 (3)0.7296 (3)0.5081 (2)0.0605 (7)
H3A1.11370.73510.46360.073*
C41.0935 (2)0.6346 (3)0.5792 (2)0.0557 (7)
C51.0217 (3)0.6238 (3)0.6468 (2)0.0596 (7)
H5A1.04330.55850.69480.072*
C60.9181 (2)0.7110 (3)0.64169 (19)0.0534 (6)
H6A0.86860.70540.68640.064*
O3A'0.5775 (3)0.8028 (3)0.17833 (16)0.0530 (5)0.786 (3)
C1A'0.5533 (3)0.7962 (2)0.42417 (12)0.0339 (4)0.786 (3)
C2A'0.6036 (3)0.8212 (3)0.34828 (19)0.0364 (5)0.786 (3)
H2AA0.68080.87450.35990.044*0.786 (3)
C3A'0.5401 (3)0.7671 (3)0.2502 (2)0.0393 (5)0.786 (3)
C4A'0.4276 (3)0.6688 (3)0.2359 (2)0.0466 (7)0.786 (3)
H4AA0.46850.58320.24970.056*0.786 (3)
H4AB0.36770.67040.16660.056*0.786 (3)
C5A'0.3411 (3)0.6942 (3)0.3040 (2)0.0437 (7)0.786 (3)
H5AA0.29540.77840.28550.052*0.786 (3)
C6A'0.4363 (3)0.7032 (3)0.4122 (2)0.0421 (6)0.786 (3)
H6AA0.38280.73080.45420.051*0.786 (3)
H6AB0.47380.61810.43470.051*0.786 (3)
C7A'0.2296 (4)0.5931 (4)0.2902 (3)0.0558 (9)0.786 (3)
H7AA0.17090.59220.22150.084*0.786 (3)
H7AB0.17530.61320.33240.084*0.786 (3)
H7AC0.27180.50960.30790.084*0.786 (3)
O3B'0.5921 (10)0.7747 (12)0.1904 (6)0.0530 (5)0.214 (3)
C1B'0.5549 (9)0.7864 (5)0.4272 (2)0.0339 (4)0.214 (3)
C2B'0.5841 (11)0.8367 (12)0.3478 (6)0.0364 (5)0.214 (3)
H2BA0.64050.90930.35520.044*0.214 (3)
C3B'0.5260 (10)0.7750 (12)0.2512 (7)0.0393 (5)0.214 (3)
C4B'0.3941 (10)0.7012 (12)0.2334 (7)0.0466 (7)0.214 (3)
H4BA0.38420.63990.17950.056*0.214 (3)
H4BB0.31690.76120.21190.056*0.214 (3)
C5B'0.3867 (10)0.6284 (10)0.3246 (6)0.0437 (7)0.214 (3)
H5BA0.45700.56000.33950.052*0.214 (3)
C6B'0.4207 (11)0.7179 (13)0.4147 (8)0.0421 (6)0.214 (3)
H6BA0.34700.78080.40530.051*0.214 (3)
H6BB0.42820.66800.47440.051*0.214 (3)
C7B'0.2415 (16)0.5623 (17)0.3043 (14)0.0558 (9)0.214 (3)
H7BA0.17110.62770.29200.084*0.214 (3)
H7BB0.24230.51200.36170.084*0.214 (3)
H7BC0.22250.50680.24690.084*0.214 (3)
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
Cl0.0536 (4)0.0905 (5)0.0885 (6)0.0121 (3)0.0112 (4)0.0009 (4)
S0.0462 (3)0.0526 (3)0.0352 (3)0.0116 (2)0.0040 (2)0.00969 (19)
O10.0640 (10)0.0465 (9)0.0670 (11)0.0130 (8)0.0142 (8)0.0008 (8)
O20.0764 (12)0.0880 (12)0.0396 (9)0.0123 (11)0.0081 (8)0.0268 (9)
N0.0399 (8)0.0581 (10)0.0253 (7)0.0102 (7)0.0103 (6)0.0050 (7)
C10.0329 (9)0.0557 (11)0.0368 (10)0.0111 (8)0.0019 (8)0.0004 (8)
C20.0531 (11)0.0599 (13)0.0486 (12)0.0120 (10)0.0170 (10)0.0062 (10)
C30.0536 (12)0.0721 (16)0.0600 (14)0.0106 (12)0.0243 (10)0.0014 (12)
C40.0339 (10)0.0649 (14)0.0592 (14)0.0056 (10)0.0026 (9)0.0020 (12)
C50.0433 (11)0.0763 (16)0.0511 (13)0.0075 (11)0.0044 (10)0.0162 (12)
C60.0404 (10)0.0725 (15)0.0426 (11)0.0100 (10)0.0070 (9)0.0114 (10)
O3A'0.0683 (9)0.0686 (13)0.0278 (8)0.0041 (9)0.0235 (7)0.0011 (7)
C1A'0.0317 (8)0.0430 (9)0.0264 (8)0.0005 (7)0.0083 (6)0.0000 (7)
C2A'0.0329 (9)0.0498 (11)0.0272 (9)0.0061 (9)0.0108 (7)0.0035 (8)
C3A'0.0405 (10)0.0513 (11)0.0274 (9)0.0008 (9)0.0129 (8)0.0024 (8)
C4A'0.0476 (14)0.0558 (16)0.0347 (11)0.0052 (12)0.0112 (10)0.0115 (10)
C5A'0.0333 (11)0.0538 (15)0.0403 (13)0.0072 (10)0.0071 (9)0.0063 (11)
C6A'0.0367 (10)0.0599 (13)0.0313 (9)0.0072 (9)0.0132 (8)0.0001 (9)
C7A'0.0404 (11)0.0595 (19)0.0639 (17)0.0150 (12)0.0122 (11)0.0074 (14)
O3B'0.0683 (9)0.0686 (13)0.0278 (8)0.0041 (9)0.0235 (7)0.0011 (7)
C1B'0.0317 (8)0.0430 (9)0.0264 (8)0.0005 (7)0.0083 (6)0.0000 (7)
C2B'0.0329 (9)0.0498 (11)0.0272 (9)0.0061 (9)0.0108 (7)0.0035 (8)
C3B'0.0405 (10)0.0513 (11)0.0274 (9)0.0008 (9)0.0129 (8)0.0024 (8)
C4B'0.0476 (14)0.0558 (16)0.0347 (11)0.0052 (12)0.0112 (10)0.0115 (10)
C5B'0.0333 (11)0.0538 (15)0.0403 (13)0.0072 (10)0.0071 (9)0.0063 (11)
C6B'0.0367 (10)0.0599 (13)0.0313 (9)0.0072 (9)0.0132 (8)0.0001 (9)
C7B'0.0404 (11)0.0595 (19)0.0639 (17)0.0150 (12)0.0122 (11)0.0074 (14)
Geometric parameters (Å, º) top
Cl—C41.740 (3)C4A'—H4AB0.9700
S—O11.426 (2)C5A'—C7A'1.509 (5)
S—O21.431 (2)C5A'—C6A'1.524 (4)
S—N1.6400 (17)C5A'—H5AA0.9800
S—C11.768 (2)C6A'—H6AA0.9700
N—C1B'1.384 (2)C6A'—H6AB0.9700
N—C1A'1.3843 (18)C7A'—H7AA0.9600
N—H1N0.833 (16)C7A'—H7AB0.9600
C1—C21.382 (4)C7A'—H7AC0.9600
C1—C61.383 (3)O3B'—C3B'1.252 (12)
C2—C31.375 (4)C1B'—C2B'1.355 (10)
C2—H2A0.9300C1B'—C6B'1.499 (11)
C3—C41.365 (4)C2B'—C3B'1.446 (11)
C3—H3A0.9300C2B'—H2BA0.9300
C4—C51.384 (4)C3B'—C4B'1.494 (12)
C5—C61.373 (4)C4B'—C5B'1.514 (12)
C5—H5A0.9300C4B'—H4BA0.9700
C6—H6A0.9300C4B'—H4BB0.9700
O3A'—C3A'1.251 (4)C5B'—C6B'1.519 (12)
C1A'—C2A'1.356 (4)C5B'—C7B'1.570 (18)
C1A'—C6A'1.498 (4)C5B'—H5BA0.9800
C2A'—C3A'1.437 (3)C6B'—H6BA0.9700
C2A'—H2AA0.9300C6B'—H6BB0.9700
C3A'—C4A'1.496 (4)C7B'—H7BA0.9600
C4A'—C5A'1.525 (4)C7B'—H7BB0.9600
C4A'—H4AA0.9700C7B'—H7BC0.9600
O1—S—O2120.11 (14)C7A'—C5A'—C4A'111.5 (3)
O1—S—N109.11 (10)C6A'—C5A'—C4A'109.4 (2)
O2—S—N104.28 (12)C7A'—C5A'—H5AA107.8
O1—S—C1108.39 (12)C6A'—C5A'—H5AA107.8
O2—S—C1108.34 (13)C4A'—C5A'—H5AA107.8
N—S—C1105.70 (10)C1A'—C6A'—C5A'112.1 (2)
C1B'—N—S127.4 (4)C1A'—C6A'—H6AA109.2
C1A'—N—S125.70 (16)C5A'—C6A'—H6AA109.2
C1B'—N—H1N114.7 (17)C1A'—C6A'—H6AB109.2
C1A'—N—H1N118.3 (16)C5A'—C6A'—H6AB109.2
S—N—H1N110.6 (15)H6AA—C6A'—H6AB107.9
C2—C1—C6121.0 (2)C2B'—C1B'—N120.6 (6)
C2—C1—S120.28 (19)C2B'—C1B'—C6B'121.5 (6)
C6—C1—S118.7 (2)N—C1B'—C6B'112.0 (6)
C3—C2—C1119.1 (2)C1B'—C2B'—C3B'118.6 (9)
C3—C2—H2A120.5C1B'—C2B'—H2BA120.7
C1—C2—H2A120.5C3B'—C2B'—H2BA120.7
C4—C3—C2119.8 (3)O3B'—C3B'—C2B'120.0 (9)
C4—C3—H3A120.1O3B'—C3B'—C4B'122.7 (9)
C2—C3—H3A120.1C2B'—C3B'—C4B'117.0 (9)
C3—C4—C5121.7 (3)C3B'—C4B'—C5B'113.7 (8)
C3—C4—Cl119.5 (2)C3B'—C4B'—H4BA108.8
C5—C4—Cl118.9 (2)C5B'—C4B'—H4BA108.8
C6—C5—C4118.8 (3)C3B'—C4B'—H4BB108.8
C6—C5—H5A120.6C5B'—C4B'—H4BB108.8
C4—C5—H5A120.6H4BA—C4B'—H4BB107.7
C5—C6—C1119.7 (3)C4B'—C5B'—C6B'110.5 (9)
C5—C6—H6A120.2C4B'—C5B'—C7B'111.5 (9)
C1—C6—H6A120.2C6B'—C5B'—C7B'111.2 (10)
C2A'—C1A'—N125.3 (2)C4B'—C5B'—H5BA107.8
C2A'—C1A'—C6A'121.7 (2)C6B'—C5B'—H5BA107.8
N—C1A'—C6A'112.7 (2)C7B'—C5B'—H5BA107.8
C1A'—C2A'—C3A'121.3 (2)C1B'—C6B'—C5B'109.7 (8)
C1A'—C2A'—H2AA119.4C1B'—C6B'—H6BA109.7
C3A'—C2A'—H2AA119.4C5B'—C6B'—H6BA109.7
O3A'—C3A'—C2A'120.4 (3)C1B'—C6B'—H6BB109.7
O3A'—C3A'—C4A'120.9 (2)C5B'—C6B'—H6BB109.7
C2A'—C3A'—C4A'118.7 (3)H6BA—C6B'—H6BB108.2
C3A'—C4A'—C5A'111.9 (2)C5B'—C7B'—H7BA109.5
C3A'—C4A'—H4AA109.2C5B'—C7B'—H7BB109.5
C5A'—C4A'—H4AA109.2H7BA—C7B'—H7BB109.5
C3A'—C4A'—H4AB109.2C5B'—C7B'—H7BC109.5
C5A'—C4A'—H4AB109.2H7BA—C7B'—H7BC109.5
H4AA—C4A'—H4AB107.9H7BB—C7B'—H7BC109.5
C7A'—C5A'—C6A'112.3 (3)
O1—S—N—C1B'53.1 (4)C6A'—C1A'—C2A'—C3A'4.8 (4)
O2—S—N—C1B'177.4 (4)C1A'—C2A'—C3A'—O3A'171.7 (3)
C1—S—N—C1B'63.2 (4)C1A'—C2A'—C3A'—C4A'7.5 (4)
O1—S—N—C1A'48.0 (2)O3A'—C3A'—C4A'—C5A'146.2 (3)
O2—S—N—C1A'177.5 (2)C2A'—C3A'—C4A'—C5A'33.0 (4)
C1—S—N—C1A'68.4 (2)C3A'—C4A'—C5A'—C7A'178.9 (3)
O1—S—C1—C29.0 (2)C3A'—C4A'—C5A'—C6A'54.2 (3)
O2—S—C1—C2140.8 (2)C2A'—C1A'—C6A'—C5A'27.7 (4)
N—S—C1—C2107.90 (19)N—C1A'—C6A'—C5A'158.0 (2)
O1—S—C1—C6169.99 (18)C7A'—C5A'—C6A'—C1A'175.5 (3)
O2—S—C1—C638.1 (2)C4A'—C5A'—C6A'—C1A'51.3 (3)
N—S—C1—C673.15 (19)C1A'—N—C1B'—C2B'40 (5)
C6—C1—C2—C30.4 (4)S—N—C1B'—C2B'28.9 (10)
S—C1—C2—C3178.6 (2)C1A'—N—C1B'—C6B'113 (6)
C1—C2—C3—C40.4 (4)S—N—C1B'—C6B'177.9 (6)
C2—C3—C4—C50.2 (4)N—C1B'—C2B'—C3B'179.2 (8)
C2—C3—C4—Cl179.7 (2)C6B'—C1B'—C2B'—C3B'30.1 (15)
C3—C4—C5—C60.0 (4)C1B'—C2B'—C3B'—O3B'147.4 (12)
Cl—C4—C5—C6179.5 (2)C1B'—C2B'—C3B'—C4B'26.1 (16)
C4—C5—C6—C10.0 (4)O3B'—C3B'—C4B'—C5B'135.8 (12)
C2—C1—C6—C50.2 (4)C2B'—C3B'—C4B'—C5B'37.6 (15)
S—C1—C6—C5178.8 (2)C3B'—C4B'—C5B'—C6B'51.1 (13)
C1B'—N—C1A'—C2A'121 (6)C3B'—C4B'—C5B'—C7B'175.3 (11)
S—N—C1A'—C2A'6.9 (4)C2B'—C1B'—C6B'—C5B'43.2 (13)
C1B'—N—C1A'—C6A'53 (6)N—C1B'—C6B'—C5B'163.8 (7)
S—N—C1A'—C6A'167.16 (19)C4B'—C5B'—C6B'—C1B'51.6 (11)
N—C1A'—C2A'—C3A'178.3 (3)C7B'—C5B'—C6B'—C1B'175.9 (10)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N—H1N···O3Bi0.83 (2)1.91 (2)2.729 (10)166 (2)
N—H1N···O3Ai0.83 (2)1.95 (2)2.777 (3)171 (2)
C5—H5A···O2ii0.932.533.337 (3)145
Symmetry codes: (i) x, y+3/2, z+1/2; (ii) x+2, y1/2, z+3/2.

Experimental details

Crystal data
Chemical formulaC13H14ClNO3S
Mr299.76
Crystal system, space groupMonoclinic, P21/c
Temperature (K)295
a, b, c (Å)10.2031 (2), 10.3267 (3), 14.1217 (3)
β (°) 108.989 (3)
V3)1406.95 (6)
Z4
Radiation typeCu Kα
µ (mm1)3.83
Crystal size (mm)0.76 × 0.61 × 0.31
Data collection
DiffractometerOxford Diffraction Gemini R
diffractometer
Absorption correctionAnalytical
[CrysAlis RED (Oxford Diffraction, 2009), based on expressions derived by Clark & Reid (1995)]
Tmin, Tmax0.119, 0.355
No. of measured, independent and
observed [I > 2σ(I)] reflections
5137, 2778, 2547
Rint0.047
(sin θ/λ)max1)0.634
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.083, 0.250, 1.07
No. of reflections2778
No. of parameters205
No. of restraints18
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å3)1.26, 0.65

Computer programs: CrysAlis CCD (Oxford Diffraction, 2009), CrysAlis RED (Oxford Diffraction, 2009), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), SHELXTL (Sheldrick, 2008).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N—H1N···O3B'i0.833 (16)1.913 (19)2.729 (10)166 (2)
N—H1N···O3A'i0.833 (16)1.951 (17)2.777 (3)171 (2)
C5—H5A···O2ii0.932.533.337 (3)145.3
Symmetry codes: (i) x, y+3/2, z+1/2; (ii) x+2, y1/2, z+3/2.
Selected geometric parameters (Å, °) calculated with X-ray and DFT top
ParametersX-rayDFT/B3LYP(3-21G**)
Cl—C41.7404 (12)1.7556
S—O11.4262 (9)1.4610
S—O21.4300 (9)1.4613
S—N1.6397 (7)1.6831
S—C11.7675 (10)1.7663
N—C1A'1.4049 (11)1.4055
O3A'—C3A'1.2376 (14)1.2415
C5A'—C7A'1.5102 (18)1.5477
O1—S—O2120.12 (5)123.44
O1—S—N109.07 (4)108.92
O2—S—N104.34 (5)103.61
O1—S—C1108.40 (5)107.79
O2—S—C1108.31 (5)108.21
N—S—C1105.69 (4)103.02
C6—C1—C2120.93 (9)121.18
C6—C1—S118.79 (8)120.04
C3—C4—C5121.65 (11)121.58
C3—C4—Cl119.40 (10)119.14
C5—C4—Cl118.95 (9)119.28
C2A'—C1A'—C6A'122.58 (8)122.53
C7A'—C5A'—C4A'110.73 (11)111.36
C1—S—N—C1A'-67.84 (8)76.42
N—S—C1—C6-73.16 (8)88.67
N—S—C1—C2107.82 (8)-92.03
S—N—C1A'—C2A'-8.93 (14)13.37
 

Acknowledgements

The authors are indebted to Mr James P. Stables, Epilepsy Branch, Division of Convulsive, Developmental and Neuromuscular Disorders, National Institute of Neurological Disorders and Stroke, for helpful discussions and the initial data. The authors wish to acknowledge E. Jeannette Andrews, EdD, Deputy Director of the Center of Excellence at Howard University College of Pharmacy, Nursing and Allied Health Sciences, for her generous assistance in completing this project. RJB wishes to acknowledge the NSF–MRI program (grant CHE-0619278) for funds to purchase the diffractometer.

References

First citationAssey, G. (2010). PhD dissertation, Howard University, Washington, DC, USA.  Google Scholar
First citationClark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887–897.  CrossRef CAS Web of Science IUCr Journals Google Scholar
First citationEdafiogho, I. O., Ananthalakshmi, K. V. & Kombian, S. B. (2006). Bioorg. Med. Chem. 14, 5266–5272.  CrossRef CAS Google Scholar
First citationEdafiogho, I. O., Kombian, S. B., Ananthalakshmi, K. V., Salama, N. N., Eddington, N. D., Wilson, T. L., Alexander, M. S., Jackson, P. L., Hanson, C. D. & Scott, K. R. (2007). J. Pharm. Sci. 96, 2509–2531.  Web of Science CrossRef CAS Google Scholar
First citationEddington, N. D., Cox, D. S., Roberts, R. R., Stables, J. P., Powell, C. B. & Scott, K. R. (2000). Curr. Med. Chem. 7, 417–36.  CAS Google Scholar
First citationFrisch, M. J., et al. (2004). GAUSSIAN03. Gaussian Inc., Wallingford, CT, USA.  Google Scholar
First citationJackson, P. L. (2009). PhD dissertation, Howard University, Washington, DC, USA.  Google Scholar
First citationMichael, J. P., de Koning, C. B., Hosken, G. D. & Stanbury, T. V. (2001). Tetrahedron, 57, 9635–9648.  Web of Science CrossRef CAS Google Scholar
First citationMichael, J. P., de Koning, C. B. & Stanbury, T. V. (1996). Tetrahedron Lett. 37, 9403–9406.  CrossRef CAS Web of Science Google Scholar
First citationOxford Diffraction (2009). CrysAlis PRO and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.  Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationStables, J. P. & Kupferburg, H. J. (1997). The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project. pp. 191–198. London: John Libbey and Co.  Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 67| Part 9| September 2011| Pages o2272-o2273
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds